Amrize Ltd (AMRZ)
NYSE
37.54
-0.65 (-1.70%)
Real-time Data
01:30 PM
Day's Range
37.3837.95
52 wk Range
37.3865.94
Financial Statements - AMRZ - Amrize Ltd
Revenue
11.81B▲ 0.9%
Net Income
1.18B▼ 16.6%Net Margin 10.0%
EBITDA
2.81B▼ 4.5%
Free Cash Flow
1.42B▼ 13.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 11.81B | 11.70B |
| Cost of Goods | 8.78B | 8.63B |
| Gross Profit | 3.03B | 3.07B |
 Operating Expense | - | - |
| Operating Income | 1.90B | 2.10B |
| Non-Operating Interest | - | - |
| Other Income Expense | 4M | 14M |
| Pre Tax Income | 1.49B | 1.82B |
| Income Tax | 326M | 415M |
| Net Income | 1.18B | 1.41B |
| EPS Basic | 2.14 | 2.56 |
| EPS Diluted | 2.14 | 2.56 |
| Basic Shares Outstanding | 553.10M | 553.30M |
| Diluted Shares Outstanding | 553.10M | 553.30M |
| Ebit | 1.91B | 2.12B |
| Ebitda | 2.81B | 2.94B |
| Net Income Continuous Operations | 1.18B | 1.27B |
| Minority Interests | 3M | 1M |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
